[ad_1]
& # 39; Speak up for Parkinson & # 39; s & # 39; s & # 39; gives the floor to 10 million people
PORTO, Portugal, April 11, 2019 / PRNewswire / – Many people with Parkinson's have a hard time making themselves heard and understood. The new BIAL film aims to give a voice to people with Parkinson's disease. "Speak up for Parkinson's" is the latest in a global campaign launched by BIAL three years ago to raise awareness about the harsh reality of people with Parkinson's disease.
Speech changes are one of the consequences of Parkinson's disease progression and can be exacerbated when people interact socially. This topic is highlighted in the new awareness campaign to be launched on the occasion of World Parkinson's Day. April 11.
The film depicts a person with Parkinson 's disease who is struggling with speech. It is based on the idea that when multiple voices speak in unison, the message is more powerful and can have far reaching impact. BIAL believes that involving multiple voices in the voices of people with Parkinson's disease will help raise awareness of the needs, challenges, frustrations and challenges experienced by people living with Parkinson's disease every day. Parkinson disease.
Parkinson's disease is a progressive neurodegenerative disease that affects brain nerve cells responsible for motor control. As the disease progresses, day-to-day tasks such as talking on the phone, ordering restaurant meals or simply expressing an idea can become real challenges. Difficulties in performing these simple actions can cause anxiety and lead to isolation. In more severe cases, patients may experience feelings of helplessness that can lead to depression.
This new film brings together the voices of those who live and interact daily with people with Parkinson's disease because, even though the disease is well understood, there is still a significant gap in terms of the diversity of difficulties encountered on a daily basis. BIAL hopes that a better understanding of the consequences of this disease could improve tolerance and help improve the quality of life of more than 10 million people with Parkinson's disease worldwide.
For Rui Sobral, Director of BIAL Global Parkinson's Department, "These patients do not have a strong enough voice yet. Most people still do not know enough about this state of health. Our intention is that this campaign breaks the taboo. We therefore need every possible voice to help patients and carers. Because of their proximity to Parkinson's patients, family caregivers, whether they are family members, friends or health care professionals, are in a unique position to clarify the limitations of this disease. This is the third year in a row that we are trying to educate everyone about Parkinson's disease. We have created an emotional campaign because life is made of emotions that are honest, because it is realistic and we hope it will touch a lot of hearts and help us better understand what it means to live with this debilitating disease.. "
Since 2017, BIAL has developed global campaigns badociated with World Parkinson Day. The purpose of these campaigns is to raise awareness about the disease and its direct and indirect consequences. The films also aim to show how some of the limitations badociated with the disease can be overcome with the understanding and support of all. Previous movies ("Me at my best" – 2017; "There is no good pace for life" – 2018), available on digital platforms, were viewed over 1.1 million of times.
BIAL is committed to this cause, Parkinson's disease. Thus, in 2018, it launched the "Parkinson's Mind" platform, which includes a website and social networks such as Facebook, LinkedIn, Twitter and Youtube, and provides content for people with Parkinson's disease, caregivers and health professionals (restricted mode).
Link to the movie "Speak Up for Parkinson & # 39; s": https://youtu.be/rDFsW0-Rq-Q
About BIAL
Founded in 1924, BIAL's mission is to research, develop and offer therapeutic solutions in the field of health. In recent decades, BIAL has focused on quality, innovation and internationalization. BIAL is strongly committed to therapeutic innovation by investing more than 20% of its annual turnover in research and development in the neurosciences and the cardiovascular system. The company plans to introduce new drugs to the market in the coming years, strengthening its international brand-name presence and achieving its goal of providing innovative products to patients around the world. For more information on BIAL: www.bial.com
About Parkinson's Disease
Parkinson's disease is a progressive and chronic neurodegenerative disease characterized by a strong reduction of the neurotransmitter dopamine, caused by the degeneration of certain neurons in the brain. Epidemiological evidence points to a complex interplay between genetic vulnerability and environmental factors. Clinical manifestations usually appear after the age of 50 (the average age of diagnosis is about 60 years). The prevalence of the disease is estimated at 300 per 100,000 population and 1 percent in the 55 to 60 age group. The European Association of Parkinson's Disease (EPDA) estimates that about 1.2 million people suffer from this disease in the European Union. The diagnosis of Parkinson's disease is based on clinical observation and can be made on patients with two major or cardinal symptoms out of three: resting tremor, muscle stiffness and bradykinesia (slow movements). Other common symptoms are postural instability, reduced facial expression and blinking, as well as a slouching posture. The disease gradually leads to disability, which affects their lives and daily activities.
Logo: https://mma.prnewswire.com/media/870247/BIAL_Logo.jpg
Related Links
http://www.bial.com/
SOURCE Bial
[ad_2]
Source link
